Your browser doesn't support javascript.
loading
Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders.
Szmit, Sebastian; Jurczak, Wojciech; Zaucha, Jan Maciej; Dlugosz-Danecka, Monika; Sosnowska-Pasiarska, Barbara; Chmielowska, Ewa; Joks, Monika; Drozd-Sokolowska, Joanna; Knopinska-Posluszny, Wanda; Spychalowicz, Wojciech; Kumiega, Beata; Charlinski, Grzegorz; Morawska, Marta; Slomian, Grzegorz.
Afiliação
  • Szmit S; Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, Otwock, Poland. Electronic address: sszmit@cmkp.edu.pl.
  • Jurczak W; Department of Hematology, Jagiellonian University, Kraków, Poland.
  • Zaucha JM; Department of Propedeutic Oncology, Medical University of Gdansk & Gdynia Oncology Center, Gdynia, Poland.
  • Dlugosz-Danecka M; Department of Hematology, Jagiellonian University, Kraków, Poland.
  • Sosnowska-Pasiarska B; Department of Oncocardiology, Holycross Cancer Center, Kielce, Poland.
  • Chmielowska E; Nicolaus Copernicus University in Torun, Poland; Clinical Oncology Department, Oncology Center in Bydgoszcz, Poland.
  • Joks M; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
  • Drozd-Sokolowska J; Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.
  • Knopinska-Posluszny W; Hematology Department, Independent Public Health Care Ministry of the Interior of Warmia and Mazury Oncology Center, Olsztyn, Poland; University of Warmia and Mazury, Olsztyn, Poland.
  • Spychalowicz W; Internal Medicine and Oncology Clinic, Silesian Medical University, Katowice, Poland.
  • Kumiega B; Departament of Hematooncology, Markiewicz Memorial Oncology Center, Brzozów, Poland.
  • Charlinski G; Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.
  • Morawska M; Hematooncology and Bone Marrow Transplantation Clinic, Lublin, Poland; St. John's Cancer Center, Lublin, Poland.
  • Slomian G; Department of Clinical Oncology, Regional Specialized Hospital No. 3, Rybnik, Poland.
Int J Cardiol ; 235: 147-153, 2017 May 15.
Article em En | MEDLINE | ID: mdl-28268088
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Doxorrubicina / Suspensão de Tratamento / Insuficiência Cardíaca / Linfoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Int J Cardiol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Doxorrubicina / Suspensão de Tratamento / Insuficiência Cardíaca / Linfoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Int J Cardiol Ano de publicação: 2017 Tipo de documento: Article